Human Genome (HGSI) Announces Novartis Withdrawals MAA for JOULFERON HCV Treatment from EMA
Tweet Send to a Friend
Human Genome Sciences, Inc. (NASDAQ: HGSI) today announced that Novartis (NYSE: NVS) has withdrawn a Marketing Authorization Application (MAA) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE